← Medical Doctors CPD
Please be informed that participation in the post-test assessment is mandatory for the issuance of certificates and the allocation of associated CPD points. Completion and passing of the post-test are required to validate your attendance and ensure compliance with CPD accreditation requirements. Thank you for your cooperation and commitment to professional development.
This Continuing Professional Development (CPD) training event, is designed to provide an in-depth exploration of the complex interactions between the cardiovascular, renal, and metabolic systems. The session will be facilitated by a team of highly skilled and distinguished resource persons with expertise in the field. This interactive, informative, and highly engaging event promises to offer valuable insights into optimizing patient care and improving outcomes in the management of Cardio-Renal Metabolic conditions.
The event will feature two critical topics:
1. Unlocking the Cardio-Renal-Metabolism Link for Better Patient Outcomes – This presentation will explore the intricate connections between the cardiovascular, renal, and metabolic systems, emphasizing the importance of understanding their interdependence for effective patient management.
2. Rationale for Early Intensification with Empagliflozin in CRM Disease Management – A deep dive into how Empagliflozin can be utilized for early intensification in CRM disease, showcasing its role in improving patient outcomes.
In addition to the engaging presentations, participants will have the opportunity to join in an interactive Q&A session, allowing for further discussion on key points and challenges. A highly anticipated panel discussion will conclude the event, providing diverse perspectives and solutions on improving clinical practice in CRM disease management.
WHY YOU SHOULD ATTEND/PARTICIPATE
This CPD training event is a must-attend for healthcare professionals who are involved in the management and care of patients with Cardio-Renal Metabolic conditions. As the interconnectivity of these systems becomes increasingly recognized as central to patient outcomes, it is crucial for General Practitioners (GPs), Family Physicians, Pharmacists, Physician Specialists, and Cardiologists to stay up-to-date with the latest evidence, treatment guidelines, and strategies for managing these complex conditions.
PROUDLY SPONSORED BY
This is a virtual event scheduled for Friday the 18th of April, 2025 at 15:30 GMT.
Target Audience: Medical Doctors
Moderator: Prof. Khaled Aldossari, Professor and Consultant Diabetologist
Date: Friday, 18th April, 2025
Time: 15:30 GMT (3:30 PM Local Time)
Don’t miss out on this exciting opportunity to elevate your skills and make a lasting impact CRM!
Overview
Course Description
This upcoming virtual CPD training event will delve into the complex interconnections between the cardiovascular, renal, and metabolic systems, offering healthcare professionals the opportunity to deepen their understanding of how these systems influence patient outcomes. Facilitated by distinguished experts, the session will explore critical topics such as the link between the cardio-renal-metabolic systems and the rationale for early intensification with Empagliflozin in CRM disease management. Attendees will gain valuable insights into diabetic guidelines, clinical practice gaps, and strategies for selecting appropriate medications tailored to patients' needs. With interactive Q&A and a panel discussion, this event provides an exciting opportunity for GPs, Family Physicians, Pharmacists, Physician Specialists, and Cardiologists to enhance their knowledge and improve clinical practices in managing CRM conditions.
What you will learn
By the end of this event, participants will be able to:
1. Understand how the cardiovascular, renal, and metabolic systems are interconnected.
2. Identify key clinical guidelines for managing Cardio-Renal Metabolic conditions, including diabetes' impact.
3. Recognize and address clinical practice gaps in CRM disease management.
4. Learn how to choose the most suitable medications for individual patients in the CRM context.
5. Understand why early intensification with Empagliflozin is important and how it improves patient outcomes in CRM disease.
Course Content
Lecture Sessions
- LIVE EVENT: Friday 18th April, 2025 @ 15:30 GMT (3:30 pm) 2 hours
Downloadables
No downloadable content added to this course yet.
Steps to Join Course
About Facilitators
- 2 Courses on CES
Prof. Mark Petrie
MD, FRCP, FESC
Cardiologist, Professor/Honorary Consultant
Institute of Cardiovascular & Medical Sciences, University of Glasgow, UK
Golden Jubilee National Hospital, Clydebank, UK
Glasgow Royal Infirmary, UK
Professor Mark Petrie, is a distinguished cardiologist and academician affiliated with the University of Glasgow, UK. Holding the position of Professor/Honorary Consultant at the Institute of Cardiovascular & Medical Sciences, University of Glasgow, he has made significant contributions to the field of cardiology throughout his illustrious career.
View full profile / courses
- 1 Course on CES
Prof. Alice Cheng
MD, PhD, FRCPC
Associate Professor || Endocrinologist
University of Toronto || Trillium Health Partners, Credit Valley Hospital || St. Michael's Hospital || Trillium Health Partners (Credit Valley)
Prof. Alice Cheng is a distinguished Endocrinologist and Professor, currently serving at both Trillium Health Partners, Credit Valley Hospital, and St. Michael's Hospital. She is also a faculty member at the University of Toronto, where she contributes to the academic development of future healthcare professionals.
View full profile / coursesRelated Courses
